Filing search / ALX Oncology Holdings Inc. / "Training" / Page 2

DEF 14A

dhv3yep4rqx4ry8s

29 Apr 21

Definitive proxy

4:01pm

10-K

g68mh593kvh9wyz

18 Mar 21

Annual report

4:25pm

8-K

EX-99.1

vz7ghaauwu qyof2

15 Mar 21

ALX Oncology Announces Appointment of Sophia Randolph, M.D., Ph.D., to Board of Directors

8:30am

424B4

ltl131it cp4

11 Dec 20

Prospectus supplement with pricing info

12:00am

DRS

edh6mcvl73 ddp0ubm0

24 Nov 20

Draft registration statement

12:00am

10-Q

3z4x v75l1n

27 Aug 20

Quarterly report

4:49pm

424B4

evg0 fbbn9byj1k811y

17 Jul 20

Prospectus supplement with pricing info

4:27pm

S-1

8e0fmvdcf01yfp 4t2y

26 Jun 20

IPO registration

4:34pm

DRS/A

7e04s8apm irrq

12 Jun 20

Draft registration statement (amended)

12:00am

DRS

qukd7g

5 May 20

Draft registration statement

12:00am